Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
Crossref DOI link: https://doi.org/10.1038/srep36518
Published Online: 2016-11-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Satpathy, Minati
Mezencev, Roman
Wang, Lijuan
McDonald, John F.
Text and Data Mining valid from 2016-11-07
Version of Record valid from 2016-11-07
Article History
Received: 27 June 2016
Accepted: 18 October 2016
First Online: 7 November 2016
Competing interests
: The authors declare no competing financial interests.